TGA - Therapeutic Goods Administration

08/04/2021 | News release | Distributed by Public on 08/03/2021 20:18

ACM meeting statement, Meeting 24, 3-4 December 2020

Section A: Pre-market registration applications referred for advice

At this meeting, the committee's advice was sought on 11 applications under evaluation by the TGA. The applications included:

  • three for the registration of a new chemical entity
  • two for the registration of a new biological entity
  • one for the registration of a new combination of active ingredients
  • five seeking extension of indications

Further details of the ACM discussion and advice associated with these items are released within the Australian Public Assessment Reports (AusPARs). Please note that there is a delay from when an application was considered at ACM and the publication of the AusPAR. To browse all AusPARs see AusPAR search.

Further information

For further information on the Advisory Committee on Medicines, please visit: Advisory Committee on Medicines.

or contact the ACM Secretary by email: [email protected](link sends e-mail).